- Home
- FBRT vs MLTX Comparison
FBRT vs MLTX Comparison
Compare FBRT & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRT
- MLTX
- Stock Information
- Founded
- FBRT 2012
- MLTX 2021
- Country
- FBRT United States
- MLTX Switzerland
- Employees
- FBRT N/A
- MLTX N/A
- Industry
- FBRT Real Estate Investment Trusts
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- FBRT Real Estate
- MLTX Health Care
- Exchange
- FBRT Nasdaq
- MLTX Nasdaq
- Market Cap
- FBRT 882.8M
- MLTX 904.7M
- IPO Year
- FBRT 1985
- MLTX N/A
- Fundamental
- Price
- FBRT $9.96
- MLTX $12.73
- Analyst Decision
- FBRT Strong Buy
- MLTX Buy
- Analyst Count
- FBRT 4
- MLTX 9
- Target Price
- FBRT $14.75
- MLTX $36.78
- AVG Volume (30 Days)
- FBRT 743.3K
- MLTX 2.4M
- Earning Date
- FBRT 10-29-2025
- MLTX 11-05-2025
- Dividend Yield
- FBRT 14.20%
- MLTX N/A
- EPS Growth
- FBRT N/A
- MLTX N/A
- EPS
- FBRT 0.80
- MLTX N/A
- Revenue
- FBRT $241,051,000.00
- MLTX N/A
- Revenue This Year
- FBRT $24.35
- MLTX N/A
- Revenue Next Year
- FBRT $7.16
- MLTX N/A
- P/E Ratio
- FBRT $12.52
- MLTX N/A
- Revenue Growth
- FBRT 32.77
- MLTX N/A
- 52 Week Low
- FBRT $9.78
- MLTX $5.95
- 52 Week High
- FBRT $13.58
- MLTX $62.75
- Technical
- Relative Strength Index (RSI)
- FBRT 34.90
- MLTX 44.10
- Support Level
- FBRT $9.78
- MLTX $9.84
- Resistance Level
- FBRT $10.20
- MLTX $13.07
- Average True Range (ATR)
- FBRT 0.21
- MLTX 0.68
- MACD
- FBRT -0.02
- MLTX 1.41
- Stochastic Oscillator
- FBRT 16.67
- MLTX 90.53
About FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.